Skip to content
The Great News – Lifestyle
Home
Sample Page
Author:
Exponential Biotherapies, Inc.
EBI Reaches Key Milestone with First Patient Enrolled in Phase III EasyBoost Trial of EA-230, a Potential First-in-Class Medicine to Accelerate Recovery After Cardiac Surgery
November 19, 2026